FDA clears MedPhoton's CBCT system

Austrian conebeam CT (CBCT) technology developer MedPhoton has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ImagingRing CBCT system.

MedPhoton has a partnership with Mevion Medical Systems, and ImagingRing will now be available to U.S. users of that company's S250i proton therapy system, Mevion said.

The ImagingRing CBCT scanner features a 102-cm bore with ceiling rail mounting; it was integrated into Mevion's S250i system at Maastro Proton Therapy in Maastricht, the Netherlands, and has been in clinical use there since February.

Page 1 of 653
Next Page